Entera Bio Ltd. — Director's Dealing 2022

Jan 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-01

Reporting Person: Ellis Sean (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-01	Stock Option (right to buy)	$2.815	A	35852	Acquired	2032-01-01	Ordinary Shares, par value NIS 0.0000769 per share (35852)	Direct
2022-01-01	Stock Option (right to buy)	$2.815	A	107557	Acquired	2032-01-01	Ordinary Shares, par value NIS 0.0000769 per share (107557)	Direct

Footnotes

F1: The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2022.

F2: The options vest ratably on a quarterly basis over a three-year period that commenced on January 1, 2022.